• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Exelixis

Exelixis

Exelixis Inc EXEL 4 Star

Last Price$1.29Day Change (%)-0.77%
Open Price$1.30Day Change ($)-0.01
Day Range1.27–1.3152-Week Range1.26–8.41

As of Wed 12/24/2014 01:00 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Exelixis ’ Collaborator Genentech Files New Drug Application for the Combination of Cobimetinib and Vemurafenib for the Treatment of Patients With BRAF V600 Mutation-Positive Advanced Melanoma

    Exelixis ’ Collaborator Genentech Files New Drug Application for the Combination of Cobimetinib and Vemurafenib for the Treatment of Patients With BRAF V600 Mutation-Positive Advanced Melanoma

  2. More Than 150 Companies Expected to Present at the 17th Annual BIO CEO & Investor Conference

    More Than 150 Companies Expected to Present at the 17th Annual BIO CEO & Investor Conference

  3. Midway Industrial Supply Acquires Contrast Equipment Company

    Midway Industrial Supply Acquires Contrast Equipment Company

  4. Is This the Year Exelixis Excels?

    The lack of early success in its lead drug's cancer trial scares the market, but we see a buying opportunity.

  5. Beware 5-Star Stocks Bearing No Moats

    Lack of competitive advantages may mean these companies aren't the bargains they seem to be.

  6. Don't Bail on Biotech

    We see opportunity as fleeing investors trigger an irrational sell-off.

  7. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  8. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.